RE:RE:RE:RE:EmpowerPharmMedipharm Labs now needs to bring a product to market to increase sales. In November 2022, the company announced its participation in an opioid trial, which I believe is the most promising trial that such a drug needs in the US, but also in Brazil. Only then should we talk about acquisitions again